RE:RE:How does Accelerated Approval work Phase 2 Ziihera is approved under the FDA’s accelerated pathway. To keep it on the market, Jazz and Zymeworks are running the Phase III HERIZON-BTC-302 confirmatory trial, which is assessing Ziihera in the first-line setting, in combination with chemotherapy with or without a PD-(L)1 blocker.